We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
476
Annaly Capital Management
NLY
$17.3B
$2.05M 0.01%
107,316
-663,188
-86% -$12.9M
GLW icon
477
Corning
GLW
$107B
$2.02M 0.01%
52,110
+7,450
+17% +$260K
CUZ icon
478
Cousins Properties
CUZ
$5.31B
$2.01M 0.01%
+86,964
New +$2M
MPWR icon
479
Monolithic Power Systems
MPWR
$61.4B
$1.99M 0.01%
2,419
+281
+13% +$203K
ADM icon
480
Archer Daniels Midland
ADM
$38.7B
$1.94M 0.01%
32,035
-3,209
-9% -$197K
CDW icon
481
CDW
CDW
$18.9B
$1.89M 0.01%
8,463
+448
+6% +$104K
PFG icon
482
Principal Financial Group
PFG
$24.3B
$1.88M 0.01%
24,026
+5,223
+28% +$424K
WST icon
483
West Pharmaceutical
WST
$23.7B
$1.88M 0.01%
5,718
-4,850
-46% -$1.71M
CLX icon
484
Clorox
CLX
$12B
$1.88M 0.01%
13,757
+665
+5% +$92.3K
HUBS icon
485
HubSpot
HUBS
$12.9B
$1.88M 0.01%
3,183
+133
+4% +$81.6K
XYZ
486
Block Inc
XYZ
$48.9B
$1.86M 0.01%
28,897
-1,248
-4% -$87.3K
MRO
487
DELISTED
Marathon Oil Corporation
MRO
$1.86M 0.01%
64,833
+6,917
+12% +$192K
EXR icon
488
Extra Space Storage
EXR
$32.3B
$1.86M 0.01%
11,943
+732
+7% +$107K
CFG icon
489
Citizens Financial Group
CFG
$30.1B
$1.85M 0.01%
51,389
-3,299
-6% -$115K
TTWO icon
490
Take-Two Interactive
TTWO
$46.1B
$1.82M 0.01%
11,677
-22,786
-66% -$3.46M
ZBH icon
491
Zimmer Biomet
ZBH
$18.8B
$1.81M 0.01%
16,709
-33,269
-67% -$3.92M
DOC icon
492
Healthpeak Properties
DOC
$15.5B
$1.81M 0.01%
92,111
+9,011
+11% +$172K
DG icon
493
Dollar General
DG
$28.4B
$1.8M 0.01%
13,584
+390
+3% +$54.5K
RMD icon
494
ResMed
RMD
$31.1B
$1.79M 0.01%
9,371
+912
+11% +$185K
LOPE icon
495
Grand Canyon Education
LOPE
$4.22B
$1.79M 0.01%
12,817
+900
+8% +$124K
GPN icon
496
Global Payments
GPN
$24.1B
$1.78M 0.01%
18,459
+1,639
+10% +$181K
COR icon
497
Cencora
COR
$62B
$1.78M 0.01%
7,897
+1,420
+22% +$329K
TEAM icon
498
Atlassian
TEAM
$26.5B
$1.74M 0.01%
9,848
+1,029
+12% +$184K
RJF icon
499
Raymond James Financial
RJF
$33.5B
$1.69M 0.01%
13,667
+1,151
+9% +$142K
CHRW icon
500
C.H. Robinson
CHRW
$20.5B
$1.68M 0.01%
19,080
-7,204
-27% -$575K

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.